Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,044,193,975
-$296,556,390 QoQ
Shares Held
47,862,796
-15.6% QoQ
Ownership
2.71%
of shares outstanding
% of Portfolio
0.84%
of 13F equity value
Holder Rank
#5
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 78%
Shared 1%
None 21%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $61,093,076,744 across 19 Drug Manufacturers - General names. ABBV ranks #3 (19.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,598,524 | $15,111,048,894 | |
| 2 | JNJ |
Johnson & Johnson
|
58,301,609 | $14,806,859,626 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
47,862,796 | $12,044,193,975 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,886,420 | $5,639,404,964 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
71,713,442 | $4,132,128,518 | |
| 6 | AZN |
Astrazeneca PLC
|
19,204,823 | $3,641,618,528 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
20,820,621 | $2,630,477,247 | |
| 8 | AMGN |
Amgen Inc
|
3,588,484 | $1,299,461,817 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,044,193,975 | 47,862,796 | Shares | Other | 2026-08-12 | |
| 2026-03-31 | $12,340,750,365 | 56,741,691 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $11,971,350,363 | 52,393,323 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $13,090,071,286 | 56,534,816 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $10,620,138,218 | 57,214,407 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $11,472,156,545 | 54,754,470 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $9,198,194,639 | 51,762,491 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $10,330,593,692 | 52,312,101 | Shares | Sole | 2024-12-26 | |
| 2024-06-30 | $9,186,253,571 | 53,557,915 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $9,368,139,953 | 51,445,030 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $8,061,995,931 | 52,022,946 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $8,232,704,231 | 55,230,808 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,648,969,693 | 56,772,580 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $9,227,294,133 | 57,898,564 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $9,843,699,673 | 60,910,214 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $7,848,467,789 | 58,479,009 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $8,593,904,847 | 56,110,635 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $8,769,210,431 | 54,094,198 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $5,836,415,367 | 43,104,988 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $4,734,776,520 | 43,893,358 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $3,938,006,356 | 34,960,994 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $3,643,204,107 | 33,664,795 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $3,251,519,780 | 30,345,495 | Shares | Other | 2021-02-19 | |
| 2020-09-30 | $2,556,802,277 | 29,190,573 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $2,812,921,688 | 28,650,659 | Shares | Other | 2020-08-11 | |
| 2020-03-31 | $1,709,763,858 | 22,440,791 | Shares | Other | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||